Clinical trial
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients.
NCT00413894 · Hoffmann-La Roche, Industry · Completed
Key facts
| NCT number | NCT00413894 |
|---|---|
| Title | A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients. |
| Official title | An Open Label Study of the Effect of Intravenous Mircera on Hemoglobin Levels in Anemic Patients With Chronic Kidney Disease Who Are on Dialysis, and Who Have Previously Received Epoetin Alfa or Beta or Darbepoetin Alfa Treatment. |
| Lead sponsor | Hoffmann-La Roche, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Anemia |
| Intervention type | Drug |
| Interventions | methoxy polyethylene glycol-epoetin beta [Mircera] |
| Enrollment | 424 |
| Start date | Mar 1, 2007 |
| Primary completion | Oct 1, 2008 |
| Completion | Oct 1, 2008 |
| First posted | Dec 20, 2006 |
| Last update posted | Feb 15, 2016 |
| Countries | Germany |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: